Our experiments indicate that the MEK1/2-ERK and NF-κB pathways are involved in visfatin-mediated upregulation of VEGF-C and VEGF-C-dependent lymphangiogenesis in ESCC cells (Figure 8). Here, MAP2K1 is linked to esophageal squamous cell carcinoma.